π Extensive Product Profile: Tadanova-D Tablets
Tadanova-D is a highly effective, prescription-only dual-action oral therapeutic formulated for the treatment of male sexual dysfunction. It combines two clinically proven active pharmaceutical ingredientsβTadalafil and Dapoxetineβto simultaneously manage erectile dysfunction (ED) and premature ejaculation (PE) in adult men. Distributed globally to fulfill retail pharmacy requirements, hospital supplies, and institutional clinical tender
.
Active Ingredients: Tadalafil + Dapoxetine
Dosage Form: Oral Film-Coated Tablet
Commercial Strengths: Available in targeted dual-action strengths (e.g., Tadalafil 20mg + Dapoxetine 60mg)
1. Clinical Indications & Usage
Tadanova-D tablets are globally indicated for:
Erectile Dysfunction (ED): For adult men who experience difficulty achieving or maintaining a penile erection sufficient for satisfactory sexual performance.
Premature Ejaculation (PE): For adult men with persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration, and before the patient wishes.
Dual Management: Indicated strictly when both conditions (ED and PE) need to be treated simultaneously in a single, convenient dose to improve patient compliance.
2. Mechanism of Action: How Tadanova-D Works
Tadanova-D exerts its therapeutic effect through a synergistic dual-mechanism pathway:
Tadalafil (PDE5 Inhibitor): During sexual stimulation, nitric oxide is released in the corpus cavernosum of the penis. Tadalafil selectively inhibits the phosphodiesterase type 5 (PDE5) enzyme. This inhibition prevents the degradation of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation and increased blood flow into the penile tissues, facilitating a natural erection.
Dapoxetine (SSRI): Premature ejaculation is linked to serotonin levels in the nervous system. Dapoxetine is a fast-acting selective serotonin reuptake inhibitor (SSRI). It inhibits the neuronal reuptake of serotonin and subsequent potentiation of the neurotransmitter at pre- and post-synaptic receptors. By increasing serotonin activity in the nervous system, it safely delays the ejaculatory reflex and extends the intravaginal ejaculatory latency time (IELT).
3. Administration and Dosing Guide
Administration Route: Tadanova-D tablets are formulated strictly for oral consumption. The tablet must be swallowed whole with a full glass of water. It must never be crushed, chewed, or split.
Dosing Schedule: The medication should be taken on an as-needed basis, approximately 1 to 3 hours before anticipated sexual activity.
Food Interactions: It can be taken with or without food. However, taking it with a heavy or high-fat meal may slightly delay the onset of the therapeutic effect.
Maximum Daily Dose: Do not exceed more than one tablet within a 24-hour period. It is not intended for continuous daily use.
4. Safety, Side Effects, and Monitoring
Tadanova-D is a potent formulation that requires clinical evaluation before use: β οΈ Contraindications & Drug Interactions:
Nitrates: Must never be taken with organic nitrates or nitric oxide donors (e.g., nitroglycerin) due to the risk of severe, life-threatening drops in blood pressure.
MAOIs & CYP3A4 Inhibitors: Contraindicated with Monoamine Oxidase Inhibitors (MAOIs), other SSRIs, or potent CYP3A4 inhibitors.
Common Side Effects: Headaches, dizziness, nausea, dyspepsia (indigestion), flushing, nasal congestion, insomnia, and transient diarrhea.
Serious Adverse Reactions: Priapism (an erection lasting longer than 4 hours, which requires immediate medical emergency care), sudden vision or hearing changes, severe orthostatic hypotension (dizziness upon standing up), and mood fluctuations.
5. Bulk Logistics, Storage, Stability & Commercial Packaging
Storage Framework: Store Tadanova-D tablets continuously under controlled room temperature below 30Β°C (86Β°F).
Environmental Safeguards: Keep the tablets sealed inside their original manufacturer blister strips and outer carton. Protect the commercial packaging from high humidity, moisture, and direct UV light exposure. Keep strictly out of reach of children.
Indian Export & Bulk Supply Excellence: Ernest Impex bridges the global healthcare gap by managing streamlined logistics for bulk pharmaceutical exports from India. Utilizing certified, moisture-barrier export packaging, robust corrugated secondary shipping boxes, and verified transit routes, we guarantee that Tadanova-D tablets arrive at international destinations with their chemical stability and clinical efficacy completely intact.
6. Regulatory and Compliance Documentation
ERNEST IMPEX provides an audit-ready compliance framework to facilitate smooth customs logistics and international clinical supply verification:
Authentic Certificate of Analysis (COA) per production batch
Validated Origin Ledger and Manufacturing Records
Global Import/Export Regulatory Compliance Papers
π‘ Why Choose ERNEST IMPEX?
Procuring urology and essential medicines through ERNEST IMPEX ensures uncompromised supply-chain reliability:
Supply-Chain Integrity
Clear Document Traceability
Logistical Security
PRESCRIPTION MEDICINE IS : YES
π Contact Ernest Impex β Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
π Websites:
π§ Email:
π¦ Business Type: Exporter | Bulk Supplier | Distributor
π² WhatsApp: +91 93599 02383
π² WhatsApp Link: